Edition:
India

People: Pacira Biosciences Inc (PCRX.OQ)

PCRX.OQ on NASDAQ Stock Exchange Global Select Market

40.86USD
15 Jul 2019
Change (% chg)

$-0.42 (-1.02%)
Prev Close
$41.28
Open
$41.24
Day's High
$41.41
Day's Low
$40.51
Volume
102,091
Avg. Vol
165,779
52-wk High
$54.92
52-wk Low
$35.09

Froimson, Mark 

Dr. Mark Froimson M.D. is Independent Director of company . Dr. Froimson has served as a director since June 2017. Dr. Froimson is a Principal at Riverside Health Advisors, a consulting company that provides strategic advice and services to health care executive leaders. Dr. Froimson recently served as the President of the American Association of Hip and Knee Surgeons. Previously, he was the Executive Vice President and Chief Clinical Officer of Trinity Health, a major national non-profit Catholic healthcare system comprising 93 hospitals in 22 states. Prior to his executive leadership position at Trinity Health, Dr. Froimson was President and Chief Executive Officer of Euclid Hospital, a Cleveland Clinic Hospital. Dr. Froimson served as a staff surgeon in the Department of Orthopedic Surgery at the Cleveland Clinic for over 16 years, during which time he held a variety of leadership positions including president of the professional staff, vice chair of the Orthopedic and Rheumatologic Institute, and member of the Board of Governors and Board of Trustees. Dr. Froimson received a B.S. in philosophy from Princeton University, an M.D. from Tulane University School of Medicine and an MBA from the Weatherhead School of Business at Case Western Reserve University.

Basic Compensation

Total Annual Compensation, USD 56,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 119,424
Fiscal Year Total, USD 175,424

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --